Old Web
English
Sign In
Acemap
>
authorDetail
>
Gwendolyn Fyfe
Gwendolyn Fyfe
Novartis
Interleukin 2
Medicine
Immunotherapy
Renal cell carcinoma
Internal medicine
3
Papers
858
Citations
0.06
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma.
2000
The cancer journal from Scientific American
Richard I. Fisher
Steven A. Rosenberg
Gwendolyn Fyfe
Show All
Source
Cite
Save
Citations (369)
High-dose aldesleukin in renal cell carcinoma: long-term survival update.
1997
The cancer journal from Scientific American
Richard I. Fisher
Steven A. Rosenberg
M. Sznol
D R Parkinson
Gwendolyn Fyfe
Show All
Source
Cite
Save
Citations (84)
CONTROLLED TRIAL OF INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS
1996
The New England Journal of Medicine
Joseph A. Kovacs
Susan Vogel
Jeffrey M. Albert
Judith Falloon
Richard T. Davey
Robert E. Walker
Michael A. Polis
Katherine Spooner
Julia A. Metcalf
Michael Baseler
Gwendolyn Fyfe
H. Clifford Lane
Robin J. Dewar
Henry Masur
Show All
Source
Cite
Save
Citations (405)
1